125 related articles for article (PubMed ID: 8959869)
1. Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion--immunopathological findings.
Pascher A; Poehlein C; Storck M; Abendroth D; Mueller-Hoecker J; Koenig W; Young VK; White DJ; Hammer C
Transpl Int; 1996; 9 Suppl 1():S385-7. PubMed ID: 8959869
[TBL] [Abstract][Full Text] [Related]
2. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor.
Pascher A; Poehlein C; Storck M; Prestel R; Mueller-Hoecker J; White DJ; Abendroth D; Hammer C
Transplantation; 1997 Aug; 64(3):384-91. PubMed ID: 9275100
[TBL] [Abstract][Full Text] [Related]
3. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
[TBL] [Abstract][Full Text] [Related]
4. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
Ramirez P; Chavez R; Majado M; Munitiz V; Muñoz A; Hernandez Q; Palenciano CG; Pino-Chavez G; Loba M; Minguela A; Yelamos J; Gago MR; Vizcaino AS; Asensi H; Cayuela MG; Segura B; Marin F; Rubio A; Fuente T; Robles R; Bueno FS; Sansano T; Acosta F; Rodriguez JM; Navarro F; Cabezuelo J; Cozzi E; White DJ; Calne RY; Parrilla P
Transplantation; 2000 Oct; 70(7):989-98. PubMed ID: 11045632
[TBL] [Abstract][Full Text] [Related]
5. Suppressed complement activation in human decay accelerating factor transgenic porcine liver cross-circulated with nonhuman primates.
Matsushita T; Ikai I; Nishitai R; Katsura N; Yamanokuchi S; Matsuo K; Sugimoto S; Shiotani T; Takahashi R; Terajima H; Yamaoka Y
Transplantation; 2003 Jun; 75(11):1807-12. PubMed ID: 12811238
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts.
Schmoeckel M; Nollert G; Shahmohammadi M; Young VK; Chavez G; Kasper-König W; White DJ; Müller-Höcker J; Arendt RM; Wilbert-Lampen U; Hammer C; Reichart B
Transplantation; 1996 Sep; 62(6):729-34. PubMed ID: 8824468
[TBL] [Abstract][Full Text] [Related]
7. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
8. Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood.
Storck M; Abendroth D; Prestel R; Pino-Chavez G; Müller-Höker J; White DJ; Hammer C
Transplantation; 1997 Jan; 63(2):304-10. PubMed ID: 9020335
[TBL] [Abstract][Full Text] [Related]
9. The function of transgenic human DAF-expressing porcine livers during hemoperfusion with human blood.
Pöhlein C; Pascher A; Storck M; Young VK; König W; Abendroth D; Wick M; Thiery J; White DJ; Hammer C
Transpl Int; 1996; 9 Suppl 1():S392-6. PubMed ID: 8959871
[TBL] [Abstract][Full Text] [Related]
10. Characterization of pigs transgenic for human decay-accelerating factor.
Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
[TBL] [Abstract][Full Text] [Related]
11. Human decay accelerating factor expressed on endothelial cells of transgenic pigs affects complement activation in an ex vivo liver perfusion model.
Pascher A; Poehlein CH; Storck M; Abendroth D; Mueller-Hoecker J; Young VK; Koenig W; White DJ; Hammer C
Transplant Proc; 1996 Apr; 28(2):754-5. PubMed ID: 8623381
[No Abstract] [Full Text] [Related]
12. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.
Schröder C; Pfeiffer S; Wu G; Zorn GL; Ding L; Allen C; Harrison RA; White DJ; Azimzadeh AM; Pierson RN
J Heart Lung Transplant; 2003 Dec; 22(12):1365-75. PubMed ID: 14672751
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo and extracorporeal perfusion with hDAF pig kidneys.
Luo Y; Levy G; Garcia BM; Yang H; Phillips J; Noble L; Chakrabarti S; Grant D; Zhong R
Xenotransplantation; 2003 Sep; 10(5):410-21. PubMed ID: 12950984
[TBL] [Abstract][Full Text] [Related]
14. Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs.
Smolenski RT; Forni M; Maccherini M; Bacci ML; Slominska EM; Wang H; Fornasari P; Giovannoni R; Simeone F; Zannoni A; Frati G; Suzuki K; Yacoub MH; Lavitrano M
Cardiovasc Res; 2007 Jan; 73(1):143-52. PubMed ID: 17134686
[TBL] [Abstract][Full Text] [Related]
15. Synthetic liver function is detectable in transgenic porcine livers perfused with human blood.
Cimeno A; French BM; Powell JM; Phelps C; Ayares D; O'Neill NA; Laird CT; Pierson RN; Azimzadeh AM; Barth RN; LaMattina JC
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29067741
[TBL] [Abstract][Full Text] [Related]
16. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.
Byrne GW; McCurry KR; Martin MJ; McClellan SM; Platt JL; Logan JS
Transplantation; 1997 Jan; 63(1):149-55. PubMed ID: 9000677
[TBL] [Abstract][Full Text] [Related]
17. Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates.
Verbakel CA; de Bruin RW; Bonthuis F; Jonker M; Dekker S; Marquet RL; IJzermans JN
Xenotransplantation; 2001 Nov; 8(4):284-91. PubMed ID: 11737854
[TBL] [Abstract][Full Text] [Related]
18. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
19. No functional benefit for hDAF-transgenic rat livers despite protection from tissue damage following perfusion with human serum.
Stockmann H; Verbakel C; Okkema P; Bonthuis F; Menoret S; Anegon I; Marquet R; IJzermans J
Transpl Int; 2002 Dec; 15(12):595-601. PubMed ID: 12478405
[TBL] [Abstract][Full Text] [Related]
20. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood.
Pierson RN; Pino-Chavez G; Young VK; Kaspar-Konig W; White DJ; Wallwork J
J Heart Lung Transplant; 1997 Feb; 16(2):231-9. PubMed ID: 9059935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
